UNIS Vienna - Flickr - CC BY-NC-ND 2.0
Réunion intersessionnelle de la CND - Sessions thématiques sur la mise en œuvre de tous les engagements internationaux en matière de politique des drogues (Décembre 2023)
Les sessions thématiques de 2023 seront structurées autour d'un bilan complet des progrès accomplis dans la mise en œuvre des réponses aux défis identifiés par le paragraphe "Bilan" de la déclaration ministérielle de 2019. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.
As per the workplan agreed upon on 24th June 2019, thematic discussions will take place every autumn during the period between 2019-23, addressing the challenges identified by the taking stock paragraph of the 2019 Ministerial Declaration.
For 2023, immediately preceding the 2014 mid-term review, there will be a comprehensive stock-taking of progress made in implementing all international drug policy commitments to address the challenges identified in the Ministerial Declaration.
Two series of thematic sessions are organised on 23-25 October and on 4-6 December. A 'Chair's summary' will be the outcome of these thematic sessions.
The thematic sessions taking place between 4-6 December 2023 (10:00 - 13:00 & 15:00 - 18:00) are structured as follows:
Day I - 4 December 2023
Morning: "Drug treatment and health services continue to fall short of meeting needs and deaths related to drug use have increased";
Afternoon: "The rate of transmission of HIV, the hepatitis C virus and other blood- borne diseases associated with drug use, including injecting drug use in some countries, remains high";
Day II - 5 December 2023
Morning: "The adverse health consequences of and risks associated with new psychoactive substances have reached alarming levels";
Afternoon: "Synthetic opioids and the non-medical use of prescription drugs pose increasing risks to public health and safety, as well as scientific, legal and regulatory challenges, including with regard to the scheduling of substances";
Day III - 6 December 2023
Morning: "The availability of internationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care, remains low to non-existent in many parts of the world";
Afternoon: 1⁄2 day closing - Way forward